Pharma-Bio Serv, Inc. 8-K

What Happened
Pharma‑Bio Serv, Inc. announced its results of operations for the quarter ended April 30, 2026. The company issued a press release on June 15, 2026 reporting those quarterly results and furnished that press release as Exhibit 99.1 to a Form 8‑K (Item 2.02).

Key Details

• Event date: June 15, 2026 (press release and Form 8‑K filing).
• Reporting period: Quarter ended April 30, 2026.
• Document furnished: Press release announcing the quarter’s results is included as Exhibit 99.1 to the 8‑K.
• Interactive data: Cover page interactive XBRL file included as Exhibit 104.

Why It Matters
This 8‑K signals that Pharma‑Bio Serv has released its latest quarterly financial results — important information for shareholders and prospective investors evaluating recent revenue, profitability, or operational trends. Review the furnished press release (Exhibit 99.1) for the full financial figures, management commentary and any forward-looking statements; that release will provide the specifics (revenue, net income/loss, margins or guidance) needed to assess near-term performance.